Demand for antibody discovery tech set to keep growing

Increasing interest in targeted therapies is driving demand in the antibody discovery market, finds industry analyst Future Market Insights.

In a research note, the group stated that the value of the market, currently worth about $8.5 billion, is expected to grow at a compound annual growth rate of 9.9% over the next decade. This would put the global market valuation at $21.8 billion by 2034.

There are a range of reasons for the strong growth outlook, including rising chronic diseases which are treatable by targeted therapies, such as cancer, diabetes, and autoimmune disorders.